This molecule is designed to integrate NMDA receptor antagonism with glucagon-like peptide-1 (GLP-1) receptor agonism, successfully reversing obesity, hyperglycemia, and dyslipidemia in rodent models
Metformin therapy and the risk of colorectal adenoma in patients with type 2 diabetes: a meta-analysis
doi: 10.1111/dom.13137 34 TrujilloJMNufferWSmithBA
Lets dig into what we actually know about GLP1 medications and breastfeeding
however, the TRANSCEND-T2D-3 study which includes people with T2D and CKD on basal insulin, will provide further insight into hypoglycaemia risk in high-risk populations
These medications can be helpful and work really well, but theyre not magicand theyre definitely not for everyone. So, what should you consider if youre interested in taking GLP-1s postpartum